Diversified Expands India Operations to Strengthen Regional Capabilities and Accelerate Enterprise Growth Across Asia-Pacific Strategic investment enhances delivery capacity as India solidifies its position as APAC’s fastest-growing Pro AV market Diversified, a leading global technology solutions provider, today announced a…
VSAVA and NEL Animal Medical Foundation Launch Vietnam’s First Comprehensive Veterinary Cardiology Series Collaborative education initiative bridges Korean and Vietnamese veterinary expertise to advance cardiology training across Asia 1. Professional press release style (clear and formal):A new gateway for collaboration…
Bruker Declares Quarterly Cash Dividends on Common and Preferred Shares BILLERICA, Mass., (BUSINESS WIRE) – Bruker Corporation (Nasdaq: BRKR, BRKRP), a global leader in scientific instruments, analytical and diagnostic solutions, today announced that its Board of Directors (“Board”) has approved…
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering RNA-based medicines to restore protein expression, today reported financial results for the third quarter ended September 30, 2025, and…
U.S. Department of Energy Renews Funding for Argonne-Led Q-NEXT Quantum Research Center The U.S. Department of Energy (DOE) today announced the renewal of funding for Q-NEXT, a National Quantum Information Science Research Center (NQISRC) led by Argonne National Laboratory, in…
Align Technology Opens 2026 Annual Research Award Program to Support Innovation in Orthodontics and Dentistry TEMPE, Ariz., [Date] – Align Technology, Inc. (NASDAQ: ALGN), a global leader in medical devices that designs, manufactures, and sells the Invisalign® System of clear…
Northwell Health Honors Recipients of Nine Endowed Chairs and Professorships, Advancing Academic Medicine and Patient Care Northwell Health announced the appointment of nine distinguished clinicians, researchers and educators to endowed chairs and professorships, including several inaugural positions spanning biomedical sciences,…
MaaT Pharma’s Pivotal Phase 3 ARES Trial Results for Xervyteg® (MaaT013) in Steroid- and Ruxolitinib-Refractory GI-aGvHD Selected for Oral Presentation at ASH 2025 MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem…
Phase III ALLEGORY trial achieved its primary and all key secondary endpoints with Gazyva, an anti-CD20 monoclonal antibody engineered to enhance B cell depletion. – Gazyva shows potential to become a transformative new standard of care for up to 3.4…
HRC Fertility, one of the largest and most respected providers of advanced fertility care in the United States, has announced its sponsorship of two major events dedicated to advancing reproductive and healthcare innovation. The organization is proudly sponsoring the 2025…